Clinical Trial to Evaluate the Safety and Immunogenicity of Ferritin Nanoparticles Expressing Native-like HIV-1 Envelope Trimers Followed by Boost With mRNA Lipid Nanoparticles Encoding a Native-like HIV-1 Envelope Trimer in Adults Without HIV
Clinical trial NCT05903339 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05903339
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-29
- Primary completion
- 2026-12-18
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.